Rob Aboud
Consejero General en Affinia Therapeutics, Inc. .
Cargos activos de Rob Aboud
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Consejero General | 01/08/2019 | - |
Historial de carrera de Rob Aboud
Antiguos cargos conocidos de Rob Aboud.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Faber Daeufer Itrato & Cabot PC
 Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Corporate Officer/Principal | 01/11/2013 | 01/08/2019 |
Formación de Rob Aboud.
| Albright College | Undergraduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Faber Daeufer Itrato & Cabot PC
Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Commercial Services |
- Bolsa de valores
- Insiders
- Rob Aboud
- Experiencia
